MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib
Crossref DOI link:
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Whicker, Margaret E.
Lin, Z. Ping
Sartorelli, Alan C.
Ratner, Elena S.
Funding for this research was provided by:
National Institute of Child Health and Human Development (K12HD047018)
Text and Data Mining valid from 2016-07-27
Version of Record valid from 2016-07-27
22 January 2016
21 July 2016
27 July 2016